The Alluvi Retatrutide 40mg + GLOW 70mg Bundle brings together two Alluvi Healthcare research formulations for customers looking to study different peptide pathways within a combined research package.

Bundle Includes

1 × Alluvi Retatrutide 40mg Pen

Retatrutide is an investigational peptide studied for its activity across GLP-1, GIP, and glucagon receptor pathways. Research has focused on metabolic signalling and related physiological mechanisms.

1 × Alluvi GLOW 70mg Pen

The Alluvi GLOW formulation contains a blend of:

• GHK-Cu – 50mg
• BPC-157 – 10mg
• TB-500 – 10mg

The formulation is presented for laboratory research involving peptide signalling, cellular pathways, and skin and tissue biology.

Combined Bundle Content

• Alluvi Retatrutide — 40mg
• Alluvi GLOW — 70mg
• 110mg total labelled peptide content

Both products shown on the packaging are supplied in pen format and are labelled for refrigerated storage.

Key Features

• Alluvi Healthcare research bundle
• 1 × Retatrutide 40mg Pen
• 1 × GLOW 70mg Pen
• 110mg combined labelled content
• GLOW contains GHK-Cu, BPC-157 & TB-500
• Retatrutide research formulation
• Suitable for controlled laboratory research
• Convenient two-product research bundle
• Refrigerated storage as stated on product packaging

How to Use (Research Reference Only)

These products are intended exclusively for laboratory and scientific research conducted by qualified professionals using appropriate research protocols.

Experimental handling, preparation, storage, and application should follow the relevant laboratory procedures and institutional requirements.

Not intended for human consumption or self-administration.

Research Applications

The individual formulations may be investigated in research involving:

• Metabolic signalling
• GLP-1, GIP and glucagon receptor pathways
• Peptide-receptor interactions
• Cellular signalling
• Tissue biology
• Peptide research
• Molecular and biochemical pathways

Research Disclaimer

For laboratory and scientific research use only.

Not intended for human consumption, therapeutic use, diagnosis, treatment, or prevention of disease.

What is the Alluvi Retatrutide 40mg + GLOW 70mg Bundle ?

The Alluvi Retatrutide 40mg + GLOW 70mg Bundle combines two Alluvi Healthcare research formulations. The bundle includes a 40mg Retatrutide Pen and a 70mg GLOW Pen containing GHK-Cu, BPC-157, and TB-500, providing researchers with two distinct peptide formulations for laboratory investigation.